| RS2475537760 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2475543943 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2475547931 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2475548694 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2475551097 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2475551311 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Autosomal recessive Alport syndrome |
| RS2475566241 |
EVC2
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2475571790 |
KIT
|
Health Risk |
Likely pathogenic |
— |
| RS2475571995 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2475578663 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2475578699 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2475578805 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2475579060 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2475580728 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2475583630 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2475583796 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2475585321 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS2475590742 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2475591015 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2475591341 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2475591669 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2475591881 |
EVC2
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2475597907 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2475602035 |
RFC1
|
Health Risk |
Pathogenic |
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome, Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome |
| RS2475626724 |
GABRA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2475627246 |
GABRA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 78 |
| RS2475629515 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475639659 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2475645750 |
GABRA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2475659360 |
PDCD10
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475664566 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475716333 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2475717504 |
SLC4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2475720206 |
TECRL
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 3, Catecholaminergic polymorphic ventricular tachycardia 3 |
| RS2475720222 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475720278 |
PDCD10
|
Health Risk |
Likely pathogenic |
— |
| RS2475721715 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475731012 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475731172 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475731521 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475745208 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2475748633 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2475748768 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2475749170 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475752862 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475753166 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475761079 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475768323 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475768684 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2475768752 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2475772649 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2475773495 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475773659 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2475774780 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2475774834 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2475777661 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2475782005 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475783849 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2475785741 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2475786944 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2475788149 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hematuria, benign familial |
| RS2475788686 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2475792758 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2475792796 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475792990 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475797794 |
REST
|
Health Risk |
Pathogenic |
— |
| RS2475800849 |
REST
|
Health Risk |
Likely pathogenic |
REST-related disorder, REST-related disorder |
| RS2475801074 |
REST
|
Health Risk |
Pathogenic |
— |
| RS2475801182 |
REST
|
Health Risk |
Likely pathogenic |
— |
| RS2475804586 |
GNRHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Isolated congenital hypogonadotropic hypogonadism, Isolated congenital hypogonadotropic hypogonadism |
| RS2475804777 |
GNRHR
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2475805410 |
GNRHR
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS2475806399 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2475808518 |
FRAS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2475808538 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475811047 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2475813744 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475814978 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2475816188 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2475817708 |
GC
|
Health Risk |
Pathogenic |
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS2475822002 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475825927 |
REST
|
Health Risk |
Likely pathogenic |
REST-related disorder, REST-related disorder |
| RS2475834136 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475838274 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475838494 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475847495 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2475851383 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2475851664 |
FRAS1
|
Health Risk |
Likely pathogenic |
FRAS1-related disorder, FRAS1-related disorder |
| RS2475854474 |
REST
|
Health Risk |
Pathogenic |
Fibromatosis, gingival |
| RS2475860796 |
TECRL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2475869362 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475869382 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475869442 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Autosomal dominant polycystic kidney disease |
| RS2475869464 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475879245 |
DSPP
|
Health Risk |
Pathogenic |
— |
| RS2475880340 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta, Dentinogenesis imperfecta |
| RS2475880409 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta, Dentinogenesis imperfecta |
| RS2475883449 |
DSPP
|
Health Risk |
Likely pathogenic |
DSPP-related disorder, DSPP-related disorder |
| RS2475883633 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475884550 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |